TRUS-probe integrated MOSkin detectors for rectal wall in vivo dosimetry in HDR brachytherapy: In phantom feasibility study

C. Tenconi, M. Carrara, M. Borroni, A. Cerrotta, D. Cutajar, M. Petasecca, M. Lerch, J. Bucci, G. Gambarini, E. Pignoli, A. Rosenfeld

Research output: Contribution to journalArticle

Abstract

The increasing complexity and high amount of dose per fraction delivered in prostate high dose rate (HDR) brachytherapy treatments call for the implementation of accurate and effective methods for the systematic and independent quality control of the overall treatment procedure. In this study, MOSkin detectors were placed on a trans-rectal ultrasound (TRUS) probe with the aim of performing both imaging and real time rectal wall in vivo dosimetry with the use of just one single instrument. After an adequate calibration of the detectors, which was carried out in a solid water phantom, the use of MOSkins integrated to the TRUS probe was studied in a gel phantom with a typical (simplified) prostate implant. Measured and calculated doses from the treatment planning system were compared, with a resulting very low average discrepancy of -0.6 ± 2.6%. The results are very promising and of particular clinical importance, however, further in vivo investigation is planned to validate the proposed method.

Original languageEnglish
Pages (from-to)379-383
Number of pages5
JournalRadiation Measurements
Volume71
DOIs
Publication statusPublished - 2014

Keywords

  • High dose rate
  • MOSFET
  • Prostate brachytherapy
  • Real-time dosimetry

ASJC Scopus subject areas

  • Radiation
  • Instrumentation

Fingerprint Dive into the research topics of 'TRUS-probe integrated MOSkin detectors for rectal wall in vivo dosimetry in HDR brachytherapy: In phantom feasibility study'. Together they form a unique fingerprint.

  • Cite this